ApprovalTrail

Approval · Notice of Compliance 4925 · 1995

TEGRETOL: Notice of Compliance 4925

Issued November 15, 1995

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number
4925
Date
November 15, 1995
Product type
Prescription Pharmaceutical
Submission
Supplement to a New Drug Submission (SNDS), supplement
Submission class
Other
Reason
Provides for oral suspension
Therapeutic class
Anticonvulsant, for symptomatic relief of trigeminal neuralgia, antimanic

Products in this notice

BrandDINStatus today
TEGRETOL02194333Marketed

Medicinal ingredients